Live Status Check

NCT07332507 Recruiting Status

Real-time enrollment status for this recurrent plasmablastic lymphoma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: November 16, 2026 at 4:54 AM UTC

NCT07332507 Status Summary

NCT NumberNCT07332507
Recruiting StatusRecruiting
ConditionRecurrent Plasmablastic Lymphoma
PhasePHASE1
Target Enrollment30 participants
Active Locations20 sites in the US
SponsorNational Cancer Institute (NCI)
Last Updated on CT.govOctober 20, 2026 (3 weeks ago)

About NCT07332507 Enrollment Status

As of November 16, 2026: Clinical trial NCT07332507 is currently recruiting participants. This phase1 study for recurrent plasmablastic lymphoma is actively seeking new participants at 20 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT07332507

Is NCT07332507 still recruiting?

Yes, NCT07332507 is actively recruiting participants as of November 16, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT07332507 recruiting?

This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT07332507?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT07332507 status last updated?

The official ClinicalTrials.gov record for NCT07332507 was last updated 3 weeks ago (October 20, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial